` DNA (DNA Group TR Ltd) vs Tel Aviv 355 Comparison - Alpha Spread

D
DNA
vs
T
Tel Aviv 355

Over the past 12 months, DNA has outperformed Tel Aviv 355, delivering a return of +50% compared to the Tel Aviv 355's +46% growth.

Stocks Performance
DNA vs Tel Aviv 355

Loading
DNA
Tel Aviv 355
Add Stock
www.alphaspread.com

Performance Gap
DNA vs Tel Aviv 355

Loading
DNA
Tel Aviv 355
Difference
www.alphaspread.com

Performance By Year
DNA vs Tel Aviv 355

Loading
DNA
Tel Aviv 355
Add Stock

Competitors Performance
DNA Group TR Ltd vs Peers

Tel Aviv 355
DNA
6861
002415
HEXA B
KEYS
Add Stock

DNA Group TR Ltd
Glance View

Market Cap
125.7m ILS
Industry
Electrical Equipment

DNA Group (T.R.)Ltd. engages in biotechnology. The firm's areas of activity include: the evaluation of bone density by measuring the velocity of the propagation of sound waves across the bone, using Bimmed, as well as the development of oral delivery of drugs, through its subsidiary, Entera Bio Ltd. Entera Bio Ltd focuses on the development of oral delivery of large molecules to address unmet medical needs. Entera Bio Ltd holds a patent, combining the following technologies: a synthetic molecule absorption enhancer, facilitating the absorption of large molecules and a proprietary formulation to prevent molecule degradation. Entera Bio Ltd’s proprietary oral delivery platform can be applied to a range of large molecules and biologicals. Entera Bio Ltd’s drugs are designated for the following medical conditions: Hypoparathyroidism and Osteoporosis.

DNA Intrinsic Value
41.54 ILS
Overvaluation 59%
Intrinsic Value
Price
D
Back to Top